+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man

Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man

Proceedings of the National Academy of Sciences of the United States of America 87(1): 473-477

Tumor-infiltrating lymphocytes (TILs) are cells generated from tumor suspensions cultured in interleukin 2 that can mediate cancer regression when adoptively transferred into mice or humans. Since TILs proliferate rapidly in vitro, recirculate, and preferentially localize at the tumor site in vivo, they provide an attractive model for delivery of exogenous genetic material into man. To determine whether efficient gene transfer into TILs is feasible, we transduced human TILs with the bacterial gene for neomycin-resistance (NeoR) using the retroviral vector N2. The transduced TIL populations were stable and polyclonal with respect to the intact NeoR gene integration and expressed high levels of neomycin phosphotransferase activity. The NeoR gene insertion did not alter the in vitro growth pattern and interleukin 2 dependence of the transduced TILs. Analyses of T-cell receptor gene rearrangement for beta- and gamma-chain genes revealed the oligoclonal nature of the TIL populations with no major change in the DNA rearrangement patterns or the levels of mRNA expression of the beta and gamma chains following transduction and selection of TILs in the neomycin analog G418. Human TILs expressed mRNA for tumor necrosis factors (alpha and beta) and interleukin 2 receptor P55 but not for interleukin 1 beta, granulocyte/macrophage colony-stimulating factor, interleukin 6, and interferon gamma when grown with high-dose interleukin 2 without subsequent activation with mitogen or specific antigen. This pattern of cytokine-mRNA expression was not significantly altered following the transduction of TILs. The NeoR gene-transduced TILs could thus be used to follow the trafficking and survival of TILs in vivo, and clinical protocols using these transduced TILs in cancer patients have begun. The studies demonstrate the feasibility of TILs as suitable cellular vehicles for the introduction of therapeutic genes into patients receiving autologous TILs.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 040312757

Download citation: RISBibTeXText

PMID: 2404283

DOI: 10.2307/2353714

Related references

Retroviral mediated gene transfer into human tumor infiltrating lymphocytes til the first authorized protocol for the use of gene transfer in man. Clinical Research 37(2): 599A, 1989

Retroviral-mediated gene transfer into human tumor-infiltrating lymphocytes. Surgical Forum 43: 472-475, 1992

Human gene transfer use of tumor infiltrating lymphocytes as cellular vehicles for cytokine gene transfer into man. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 2): 1141, 1990

Retroviral mediated gene transfer of interleukin 6 and interleukin 7 into human tumor infiltrating lymphocytes. Surgical Forum (Chicago) 42: 470-472, 1991

Retroviral mediated TNF gene transfer into tumor infiltrating lymphocytes. Journal of China Medical University 24(1): 4-7, 1995

Transfer and expression of the neomycin resistance gene neo r in human tumor infiltrating lymphocytes using retroviral vectors. FASEB Journal 3(3): A670, 1989

Retroviral mediated gene transfer into cultured lymphocytes use as markers for cell traffic and as vehicles for gene therapy. Pediatric Research 25(4 Part 2): 161A, 1989

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New England Journal of Medicine 323(9): 570-578, 1990

Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells. Cancer Immunology ImmunoTherapy 32(6): 342-352, 1991

Long-term expression of gene introduction into normal human T-lymphocytes by retroviral-mediated gene transfer. Journal of Cellular Biochemistry 45(4): 353-358, 1991

Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. Journal of Clinical Oncology 13(2): 410-418, 1995

Retroviral-mediated gene transfer in human primary T lymphocytes Impact of the type of stimulation on TCRB repertoire of gene-modified cells. Experimental Hematology (Charlottesville) 30(6 Suppl. 1): 116, 2002

Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. Transplantation Proceedings 23(1 Pt 1): 170-171, 1991

Retroviral-mediated gene transfer in primary murine and human T-lymphocytes. Molecular Biotechnology 15(2): 133-142, 2000

Retroviral-Mediated Gene Transfer in Human Primary T Lymphocytes Induces an Activation- and Transduction/Selection-Dependent TCRBV Repertoire Skewing of Gene-Modified Cells. Blood 100(11): Abstract No 2556, 2002